Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles15 certified filings for “Associate Director Oncology Outcomes Research” (Medical Scientists, Except Epidemiologists) in MD: $126k–$185k, median $140k.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles
- 15 certified filings for “Associate Director Oncology Outcomes Research” (Medical Scientists, Except Epidemiologists) in MD: $126k–$185k, median $140k. Most were filed at wage level II (47%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
Introduction to Role
As Senior Director, Cell Therapy Partnerships & Strategy – Neurology, you will shape and execute AstraZeneca’s global Cell Therapy Strategic Site Partnership strategy, with Neurology as a primary focus. Working at the intersection of clinical development, clinical trial execution, and commercial readiness, you will help establish a differentiated AstraZeneca presence across the cell therapy and neurology ecosystem.
You will lead strategic relationships with Key External Experts (KEEs), including leading neurology and cell therapy investigators, and priority clinical sites across our global portfolio. By developing a high-performing network of strategic partners, you will expand site and patient access, strengthen clinical trial delivery, and create long-term value that supports future commercial success.
Why This Role
This is an opportunity to define how AstraZeneca collaborates with leading neurology experts, investigators, treatment centers, and healthcare systems to advance cell therapy clinical development. You will bring deep scientific and clinical trial expertise to site strategy, helping partners overcome infrastructure, capacity, referral, and operational barriers that can limit delivery of complex therapies.
Your work will support the development of scalable cell therapy networks across academic and community settings, strengthen AstraZeneca’s position as a preferred partner, and help prepare sites for the transition from clinical development to commercial delivery.
Accountabilities
Strategic Cell Therapy Partnership Development and Management
• Own the disease-area site partnership strategy across the cell therapy portfolio, with Neurology as a strategic priority.
• Identify, establish, and manage strategic partnerships with high-impact clinical sites globally to support AstraZeneca’s cell therapy portfolio across Neurology and other priority indications.
• Lead strategic site partnership governance and engagement for assigned strategic sites.
• Serve as the primary relationship owner for select strategic partners, supporting alignment, issue resolution, and joint value creation.
• Cultivate trusted relationships with Key Opinion Leaders (KOLs), Key External Experts, investigators, clinical and administrative site leaders, and relevant external vendors.
• Build strong partnerships with leading neurology and cell therapy investigators and institutions.
• Represent AstraZeneca at industry meetings and scientific congresses, including ASH, EHA, AAN, ECTRIMS, and other relevant cell therapy and neurology forums.
• Strengthen AstraZeneca’s visibility and reputation as a collaborative, neurology-focused cell therapy partner.
• Exercise strategic ownership and cross-functional influence across complex initiatives that require senior-level judgment and coordination.
Global Cell Therapy Site Strategy
• Shape, own, and execute AstraZeneca’s global cell therapy site network strategy, with Neurology at the forefront alongside Hematology, Oncology, Biopharma, Rare Disease, and emerging therapeutic areas.
• Identify and engage clinical sites that are critical to clinical trial participation, operational delivery, and scalable patient access.
• Develop solutions that expand access to cell therapy, including delivery through community-based settings where appropriate.
• Apply deep clinical and clinical trial expertise to address Neurology-specific site, patient, and treatment-delivery requirements.
• Collaborate across Site Management, Clinical Operations, External Alliances, Medical Affairs, Commercial, Clinical Development, Manufacturing, and other functions to align and coordinate site strategies.
• Engage with sites to understand and address barriers to cell therapy delivery at scale, includ
Apply on employer site ↗